- Home
- NEOV vs RPTX Comparison
NEOV vs RPTX Comparison
Compare NEOV & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEOV
- RPTX
- Stock Information
- Founded
- NEOV 2018
- RPTX 2016
- Country
- NEOV United States
- RPTX Canada
- Employees
- NEOV N/A
- RPTX N/A
- Industry
- NEOV Industrial Machinery/Components
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- NEOV Miscellaneous
- RPTX Health Care
- Exchange
- NEOV Nasdaq
- RPTX Nasdaq
- Market Cap
- NEOV 72.2M
- RPTX 63.9M
- IPO Year
- NEOV N/A
- RPTX 2020
- Fundamental
- Price
- NEOV $3.09
- RPTX $1.41
- Analyst Decision
- NEOV Strong Buy
- RPTX Strong Buy
- Analyst Count
- NEOV 1
- RPTX 3
- Target Price
- NEOV $7.50
- RPTX $4.50
- AVG Volume (30 Days)
- NEOV 160.7K
- RPTX 94.4K
- Earning Date
- NEOV 05-09-2025
- RPTX 08-05-2025
- Dividend Yield
- NEOV N/A
- RPTX N/A
- EPS Growth
- NEOV N/A
- RPTX N/A
- EPS
- NEOV N/A
- RPTX N/A
- Revenue
- NEOV $4,255,136.00
- RPTX $1,073,000.00
- Revenue This Year
- NEOV $208.50
- RPTX N/A
- Revenue Next Year
- NEOV $128.75
- RPTX N/A
- P/E Ratio
- NEOV N/A
- RPTX N/A
- Revenue Growth
- NEOV 52.64
- RPTX N/A
- 52 Week Low
- NEOV $1.80
- RPTX $0.89
- 52 Week High
- NEOV $6.11
- RPTX $4.29
- Technical
- Relative Strength Index (RSI)
- NEOV 47.07
- RPTX 51.83
- Support Level
- NEOV $2.80
- RPTX $1.33
- Resistance Level
- NEOV $3.04
- RPTX $1.48
- Average True Range (ATR)
- NEOV 0.24
- RPTX 0.05
- MACD
- NEOV -0.04
- RPTX -0.01
- Stochastic Oscillator
- NEOV 17.65
- RPTX 34.37
About NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.